Veracyte, Inc. (VCYT): Price and Financial Metrics

Veracyte, Inc. (VCYT): $36.46

-3.43 (-8.60%)

POWR Rating

Component Grades













Add VCYT to Watchlist
Sign Up

Industry: Biotech


of 493

in industry


  • Growth is the dimension where VCYT ranks best; there it ranks ahead of 94.58% of US stocks.
  • VCYT's strongest trending metric is Quality; it's been moving up over the last 200 days.
  • VCYT ranks lowest in Sentiment; there it ranks in the 7th percentile.

VCYT Stock Summary

  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.07 for Veracyte Inc; that's greater than it is for merely 8.03% of US stocks.
  • Over the past twelve months, VCYT has reported earnings growth of 212.39%, putting it ahead of 91.42% of US stocks in our set.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for VCYT comes in at -29.94% -- higher than that of only 8.85% of stocks in our set.
  • Stocks that are quantitatively similar to VCYT, based on their financial statements, market capitalization, and price volatility, are DRQ, SPT, SILK, TRUE, and IVAC.
  • Visit VCYT's SEC page to see the company's official filings. To visit the company's web site, go to

VCYT Price Target

For more insight on analysts targets of VCYT, see our VCYT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $83.17 Average Broker Recommendation 1.5 (Moderate Buy)

VCYT Stock Price Chart Interactive Chart >

Price chart for VCYT

VCYT Price/Volume Stats

Current price $36.46 52-week high $86.03
Prev. close $39.89 52-week low $22.69
Day low $36.06 Volume 1,106,464
Day high $39.66 Avg. volume 944,306
50-day MA $49.73 Dividend yield N/A
200-day MA $46.99 Market Cap 2.45B

Veracyte, Inc. (VCYT) Company Bio

Veracyte Inc. operates as a molecular diagnostics company in the United States. It operates in the field of molecular cytology with genomic solutions that resolve diagnostic ambiguity and enable physicians to make informed treatment decisions at an early stage in patient care. The company was founded in 2006 and is based in San Francisco, California.

VCYT Latest News Stream

Event/Time News Detail
Loading, please wait...

VCYT Latest Social Stream

Loading social stream, please wait...

View Full VCYT Social Stream

Latest VCYT News From Around the Web

Below are the latest news stories about Veracyte Inc that investors may wish to consider to help them evaluate VCYT as an investment opportunity.

Veracyte, Inc. (VCYT) CEO Bonnie Anderson on Q1 2021 Results - Earnings Call Transcript

Veracyte, Inc. (VCYT) Q1 2021 Earnings Conference Call May 10, 2021 16:30 ET Company Participants Tracy Morris - Vice President, Corporate Communications and Investor Relations Bonnie Anderson - Chairman and Chief Executive Officer Jane Alley - Acting Chief Financial Officer Marc Stapley - Incoming Chief Executive Officer Giulia Kennedy -...

SA Transcripts on Seeking Alpha | May 11, 2021

Veracyte (VCYT) Reports Q1 Loss, Tops Revenue Estimates

Veracyte (VCYT) delivered earnings and revenue surprises of 8.33% and 6.33%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 10, 2021

Veracyte, Inc. Announces CEO Succession Plan

Veracyte, Inc. Announces CEO Succession Plan -- Bonnie Anderson to Assume Active Role as Executive Chairman; Marc Stapley to Become CEO

Yahoo | May 10, 2021

Veracyte Announces First Quarter 2021 Financial Results

Veracyte Announces First Quarter 2021 Financial Results

Yahoo | May 10, 2021

Veracyte, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 10, 2021 / Veracyte, Inc. (NASDAQ:VCYT) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 10, 2021 at 4:30 PM Eastern Time.

Yahoo | May 10, 2021

Read More 'VCYT' Stories Here

VCYT Price Returns

1-mo -29.41%
3-mo -51.33%
6-mo -21.82%
1-year 38.08%
3-year 467.03%
5-year 606.59%
YTD -25.50%
2020 75.29%
2019 121.94%
2018 92.65%
2017 -15.63%
2016 7.50%

Continue Researching VCYT

Want to see what other sources are saying about Veracyte Inc's financials and stock price? Try the links below:

Veracyte Inc (VCYT) Stock Price | Nasdaq
Veracyte Inc (VCYT) Stock Quote, History and News - Yahoo Finance
Veracyte Inc (VCYT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8898 seconds.